The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Castle Biosciences Inc shares valued at $384,449 were purchased by Kristen M. Oelschlager on Aug 27 ’25. At $21.35 per share, Kristen M. Oelschlager acquired 18,007 shares.
Also, Kristen M. Oelschlager purchased 25,355 shares, netting a total of over 541,329 in proceeds.
Before that, MAETZOLD DEREK J had sold 1,339 shares from its account. In a trade valued at $26,834, the Pres. & Chief Exec. Officer traded Castle Biosciences Inc shares for $20.04 each. Upon closing the transaction, the insider’s holdings decreased to 1,339 shares, worth approximately $1.52 million.
As published in their initiating research note from Guggenheim on December 14, 2023, Castle Biosciences Inc [CSTL] has been a Buy and the price target has been revised to $25. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in early January. As of January 07, 2022, Stephens has initiated its “an Overweight” rating for CSTL. Earlier on April 30, 2021, Lake Street initiated its rating. Their recommendation was “a Buy” for CSTL stock.
Analyzing CSTL Stock Performance
On last trading session, Castle Biosciences Inc [NASDAQ: CSTL] rose 4.36% to $22.28. The stock’s lowest price that day was $21.24, but it reached a high of $22.35 in the same session. During the last five days, there has been a surge of approximately 12.64%. Over the course of the year, Castle Biosciences Inc shares have dropped approximately -24.65%. Shares of the company reached a 52-week high of $32.74 on 01/08/25 and a 52-week low of $14.59 on 08/04/25.
Support And Resistance Levels for Castle Biosciences Inc (CSTL)
According to the 24-hour chart, there is a support level at 21.56, which, if violated, would cause prices to drop to 20.85. In the upper region, resistance lies at 22.67. The next price resistance is at 23.07. RSI (Relative Strength Index) is 69.88 on the 14-day chart, showing neutral technical sentiment.
Is Castle Biosciences Inc subject to short interest?
Stocks of Castle Biosciences Inc saw a sharp steep in short interest on 2025-08-15 dropping by -0.12 million shares to 1.29 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 1.41 million shares. A decline of -9.63% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.98 of the overall float, the days-to-cover ratio (short ratio) decline to 1.98.
Which companies own the most shares of Castle Biosciences Inc (CSTL)?
In terms of Castle Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 33.5 in the next 12 months, up nearly 56.91% from the previous closing price of $21.35. Analysts anticipate Castle Biosciences Inc stock to reach 37 by 2025, with the lowest price target being 30. In spite of this, 3 analysts ranked Castle Biosciences Inc stock as Buy at the end of 2025. On November 10, 2020, KeyBanc Capital Markets assigned a price target of “an Overweight” to the stock and initiated coverage with a $70.
